Novo Nordisk A/S

NONOF ·Healthcare, Drug Manufacturers - General, Denmark
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Mar 4, 2026
6-K Mar 2, 2026 FORM 6-K
6-K Mar 2, 2026 FORM 6-K
6-K Feb 23, 2026 FORM 6-K
6-K Feb 23, 2026 FORM 6-K
6-K Feb 20, 2026 FORM 6-K
6-K Feb 17, 2026 FORM 6-K
6-K Feb 11, 2026 FORM 6-K
6-K Feb 10, 2026 FORM 6-K
6-K Feb 9, 2026 FORM 6-K
6-K Feb 5, 2026 FORM 6-K
6-K Feb 5, 2026 FORM 6-K
6-K Feb 5, 2026 FORM 6-K
IRANNOTICE Feb 4, 2026 IRANNOTICE
20-F Feb 4, 2026 20-F
6-K Feb 4, 2026 6-K
6-K Feb 3, 2026 6-K
6-K Feb 3, 2026 FORM 6-K
6-K Feb 2, 2026 FORM 6-K
6-K Feb 2, 2026 FORM 6-K
6-K Dec 23, 2025 FORM 6-K
6-K Nov 25, 2025 FORM 6-K
6-K Nov 24, 2025 FORM 6-K
6-K Nov 17, 2025 FORM 6-K
6-K Nov 14, 2025 FORM 6-K
← Newer Page 3 of 82 · 2047 filings Older →